INTRODUCTION
The International Cooperative Study on the Timing of Aneurysm Surgery demonstrated that aneurysmal subarachnoid hemorrhage (SAH) patients who underwent surgery on days 4e10 post-hemorrhage had worse outcomes than patients treated on days 0e3 or 11e14. 1 2 One conclusion of these results is that patients who present on posthemorrhage days 4e10 should have clipping delayed until after day 10. Since the study, endovascular coil embolization has become a treatment for ruptured cerebral aneurysms and it is unclear whether the surgical results from the International Cooperative Study apply to this new treatment modality.
Our institution is a regional referral center for SAH and patients are transferred, for various reasons, at different time points after hemorrhage. While the vast majority of our patients are transferred within the first 48 h, a significant minority arrive days later, during the suboptimal post-hemorrhage day 4e10 period. Our protocol is to treat the ruptured aneurysm, with endovascular coil embolization if possible, within 24 h of admission. This differs from the recommendation of the International Cooperative Study on the Timing of Aneurysm Surgery, which recommends delaying treatment until after day 10. We reviewed our experience to determine whether it is safe to coil aneurysm patients that present on post-SAH days 4e10.
PATIENTS AND METHODS
This study was conducted under an Institutional Review Board approved protocol in accordance with the Health Insurance Portability and Accountability Act standards for the protection of patient privacy. We reviewed a clinical database of the University of Florida neurovascular team from January 2006 through June 2008, for all patients with aneurysmal SAH who underwent endovascular coil embolization by the senior author as a primary treatment modality for a ruptured aneurysm. We recorded patient demographics and baseline clinical factors, including age, gender, aneurysm location (anterior or posterior circulation), maximal diameter, admission HunteHess grade, Fisher score, post-hemorrhage day on arrival, post-hemorrhage day upon coiling and the presence of vasospasm. Discharge disposition (deceased, skilled nursing facility, rehab or home) was recorded as the primary measure of clinical outcome.
Standard SAH treatment protocols at our institution were employed for all patients. Our standard SAH treatment protocol included ventriculostomy drainage for management of hydrocephalus, oral nimodipine (60 mg every 4 h) through day 21, magnesium sulfate (12.5 g per day via continuous infusion) through day 14 and simvastatin (40 mg daily).
We grouped patients for our analysis into cohorts based on the time frames as described in the International Cooperative Study for the Timing of Aneurysm Surgery. 2 Treatment cohorts included post-hemorrhage days 0e3, 4e10 and 11e21. Statistical analyses were then performed to confirm similarity between cohort demographics, to analyze differences in discharge disposition and to identify predictors of poor outcome.
Statistical analysis
Statistical analysis was performed using SAS 9.1 (SAS Inc.). The ManteleHaenszel test statistic for contingency tables was computed to determine the association between timing of coiling and mortality and discharge disposition. Multivariate logistic regression models were chosen to associate death or poor clinical outcome with important demographic and clinical variables. A type I error rate of 0.05 was used to determine the significance of all testing results.
RESULTS
From January 2006 to June 2008, 119 ruptured cerebral aneurysms in 119 patients were coiled by the senior author. The vast majority, 102 (85.7%), underwent endovascular coiling on days 0e3, 14 (11.8%) underwent coiling on days 4e10, while only 3 (2.5%) underwent coiling on days 11e21. Due to the small number of patients in the late treatment cohort, only those patients treated on days 0e3 and 4e10 were directly compared. Patient demographic data and clinical characteristics of the cohorts are listed in table 1. There were no significant differences in gender, age, aneurysm location, HunteHess grade or Fisher Score between these groups. The only significant difference was average aneurysm size. Average size was 8.9 mm in the day 0e3 cohort and 6.6 mm in the day 4e10 cohort. This difference can be attributed to a few giant aneurysms treated on days 0e3. The day 0e3 cohort had 27 (26%) aneurysms exceeding 10 mm in size, where the day 4e10 group had only 2 (14%).
Mortality and discharge disposition of patients in these cohorts were similar. Of those treated on post-hemorrhage days 0e3, 33% were discharged home, 32% to inpatient rehab, 9% to a skilled nursing facility and 26% died. Of those treated on posthemorrhage days 4e10, 43% were discharged home, 14% to rehab, 29% to a skilled nursing facility and 14% died. Table 2 & figure 1 depict the mortality and discharge disposition for these cohorts.
Multivariate logistic regression analysis was performed on the outcome of death, using factors including timing of coiling, age, gender, aneurysm location, HunteHess grade and Fisher score. For each factor, we computed statistical p-values (p) and ORs with their 95% CIs from our multivariate models. For timing of coiling (p¼0.6621), the odds of death for patients treated on days 0e3 is 1.494 (95% CI between 0.247 and 9.032) times the odds of death for patients treated on days 4e10. For age (p¼0.0004), a 1-year increase in age had an OR of 1 Several recent observational studies have had similar results and have supported the finding that early versus late surgical intervention have equivalent outcomes. 5 6 What has not been well studied in the literature is whether or not timing of endovascular coiling has implications on outcome. There has been increasing utilization of endovascular coil embolization for treatment of ruptured aneurysms over the past two decades. The only large review of the timing of endovascular treatment of aneurysms, by Baltsavius 7 in 2000, demonstrated that timing of coiling did not affect 6-month outcome. Recently, the International Subarachnoid Aneurysm Trial (ISAT) demonstrated that for patients who could undergo either surgical clipping or endovascular coiling for a ruptured aneurysm, those who had coiling were more likely to be independent at both 1 and 7 years post-hemorrhage. 8 Our protocol is to treat ruptured aneurysms within 24 h of admission, and we do not advocate delayed treatment of intracranial aneurysms. Our institution is a regional referral center for SAH and a single neurovascular team offers both surgical clipping and endovascular coil embolization. We have had a number of patients who either presented, were transferred to our facility or were stabilized for coiling on post-hemorrhage days 4e10. Our goal for this study was to show that endovascular treatment during this 'high-risk' period is safe and that aneurysm coiling should not be delayed until after day 10.
In this retrospective study of 119 patients who underwent coiling of a ruptured aneurysm, there was no significant difference in age, gender, aneurysm location (anterior or posterior circulation), pretreatment HunteHess grade or Fisher score between those coiled on post-hemorrhage days 0e3 and those treated on days 4e10. The only significant difference in preprocedure medical characteristics was the larger aneurysm size in the early treatment cohort (8.9 mm vs 6.6 mm). We feel this is attributable to the presence of 27 aneurysms in excess of 10 mm in this group that skewed the average size of the cohort. If the outlying data points of the giant aneurysms are excluded, the average size of the two groups is not significantly different.
We found that mortality and discharge disposition in the cohort treated on days 0e3 was not statically different from those treated on days 4e10. They had similar rates of death, discharge to nursing facilities, rehab and home. Multivariate regression analyses did not find timing of coiling (either days 0e3 or days 4e10) to be a predictor of death or poor outcome. Regression analyses found both age and HunteHess grade to be significant predictors of death and poor outcome. Our results suggest that coiling on post-hemorrhage days 4e10 does not correlate with increased mortality or worsened discharge disposition.
There was a significantly higher rate of vasospasm at the time of treatment for those patients treated on days 4e10 when compared with the day 0e3 cohort. Five of 14 patients (36%) in the day 4e10 group had vasospasm at the time of coiling, while only 5 of 103 patients (5%) in the day 0e3 group had evidence of radiographic spasm at the time of treatment. Of the five patients in the day 4e10 cohort that presented with vasospasm at the time of treatment, all five were treated with intra-arterial verapamil and one required balloon angioplasty for treatment at the time of coiling. A significant proportion of the morbidity in the day 4e10 group was associated with vasospasm at the time of treatment. Of the five patients in this group who had vasospasm, only one improved to the point of being discharged home, one died and three required long-term skilled nursing care or longterm rehab care. It appears that those patients who arrive during the day 4e10 period who are in moderate to severe vasospasm have a trend toward worse outcomes than those who are not in vasospasm at the time of treatment. Nevertheless, if those patients who presented in vasospasm did not undergo coiling at the time of presentation, it is likely that they would have succumbed to vasospasm. By treating these patients immediately we were able to diagnose and perform treatment for vasospasm at the time of aneurysm coiling.
Several weaknesses are inherent in this study. First, it is retrospective in nature and may therefore contain selection bias that is not immediately apparent. Second, we acknowledge that other factors throughout the hospital course of a SAH patient may contribute to morbidity and mortality. We did not attempt to record or analyze stroke rate, ICU complications, hydrocephalus, presence of external ventricular drain, seizures or need for ventriculoperitoneal shunt placement. Third, our sample size was small, which may limit our ability to detect a difference if one truly exists.
CONCLUSIONS
Endovascular coil embolization of ruptured intracranial aneurysms may be performed safely on patients who arrive on post-hemorrhage days 4e10, without significant increase in mortality or poor outcome and despite a higher rate of vasospasm at the time of treatment. Coil embolization need not be delayed until after day 10, as the results of the Timing of Aneurysm Surgery Study initially suggested for surgical clipping. For
Key messages
< The International Cooperative Study on the Timing of Aneurysm Surgery concluded that patients that present with subarachnoid hemorrhage (SAH) on post-hemorrhage days 4e10 should have aneurysm surgery delayed until after day 10. < Since the study, coiling has become a treatment option and it is unclear whether these surgical results apply to aneurysm coiling, particularly for patients who arrive at regional SAH referral centers during the suboptimal post-hemorrhage days 4e10. < We reviewed 119 consecutive SAH patients treated at our facility and conducted a regression analysis to determine the effect of day of coiling on clinical outcome at discharge. < Age and HunteHess grade were the only predictors of mortality and poor outcome, and day of coiling (days 0e3 versus days 4e10) had no effect on mortality or poor outcome. < Coiling of ruptured aneurysms can be performed safely on patients who arrive on post-hemorrhage days 4e10, and endovascular treatment need not be delayed until after day 10.
